Novartis Pharmaceuticals Corp. et al.; Withdrawal of Approval of 27 New Drug … – TradingMarkets.com
SUMMARY: The Food and Drug Administration (FDA) is withdrawing approval of 27 new drug applications (NDAs) and 58 abbreviated new drug applications (ANDAs) from multiple applicants. The holders of the applications …
